Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 697

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 697
---

Yoshiki Sato

Email: [Omitted]

[Omitted]

[Omitted]

with a copy (which will not constitute notice) to:

Mori Hamada & Matsumoto

16th Floor, Marunouchi Park Building

2-6-1 Marunouchi,
Chiyoda-ku

Tokyo 100-8222, Japan

Attn: Seiichi Okazaki

Takaya Sato

Email: seiichi.okazaki@mhm-global.com

takaya.sato@mhm-global.com

McDermott Will & Emery LLP

2049 Century Park East, Suite 3200

Los Angeles, CA 90067-3206

Attn: Matt Carter

David A. Lipkin

Email: mcarter@mwe.com

dlipkin@mwe.com

B-8

if to Seller, to:

Aadi Bioscience, Inc.

17383
Sunset Boulevard, Suite A250

Pacific Palisades, California 90272

Attn: David Lennon

Steve Rodin

Email: [Omitted]

[Omitted]

with a copy (which will not constitute notice) to:

Wilson Sonsini Goodrich & Rosati, P.C.

12235 El Camino Real

San
Diego, California 92130

Attn: Dan Koeppen

Robert L. Wernli, Jr.

Ethan Lutske

Jack Hamilton

Email: dkoeppen@wsgr.com

rwernli@wsgr.com

elutske@wsgr.com

jhamilton@wsgr.com

if to Stockholder, to the address set forth on to this Agreement.

(h) . Stockholder shall not be liable for any breach of the terms of any agreement similar to this Agreement by
any other Seller Stockholder. Nothing in this Agreement shall be interpreted as creating or forming a “group” with any other Person for the purposes of Rule 13d-5(b)(1) of the Exchange Act or for any
other similar provision of Law.

(i) . At all times commencing with the execution and delivery of this
Agreement and continuing until the Expiration Time, in furtherance of this Agreement, Stockholder hereby authorizes Seller or its counsel to notify Seller’s transfer agent that there is a stop transfer order with respect to all the Subject
Shares (and that this Agreement places limits on the voting and transfer of such Subject Shares), subject to